Skin cancer — all decisions

The Board granted service connection for hypertension, finding it manifested to a compensable degree within one year of the Veteran's separation from service. The other claims were remanded for further development.

The Board remands the claim for an adequate medical opinion to address the Veteran's in-service exposures, including asbestos and toxic chemicals.

The appeal for service connection for melanoma has been withdrawn by the Appellant.

The Board granted service connection for skin cancer, finding that it was at least as likely as not caused by chronic sun exposure during the Veteran's service.

The Board remands the service connection claims for hearing loss, tinnitus, skin cancer, and conditions of the right shoulder, left hip, left knee, and left ankle due to a pre-decisional duty-to-assist error in failing to obtain the Veteran's service records.

The Board remands the Veteran's claims for service connection for various conditions, including a psychiatric disability, sleep disorder, skin cancer residuals, prostate cancer residuals, chronic obstructive pulmonary disease (COPD), and dementia, due to insufficient evidence regarding his Vietnam or Thailand service.

The Board granted the restoration of a 100 percent rating for melanoma and SMC at the housebound rate, effective August 1, 2024.

The Board granted service connection for left ear otalgia and melanoma, resolving reasonable doubt in the Veteran's favor.

The Board granted service connection for skin cancers, to include squamous cell and basal cell carcinoma, based on the evidence showing a current diagnosis of skin cancer and exposure to sun during ACDUTRA.

The Board remands the claims for service connection for chloracne, skin cancer, rhinophyma, rheumatoid arthritis, and lung condition due to pre-decisional duty to assist errors.

The veteran withdrew the appeals seeking service connection for various conditions, including skin cancer, diabetes mellitus, and peripheral neuropathy.

The Board granted service connection for melanoma and basal cell carcinoma, finding that these conditions are related to the Veteran's service.

The Board granted service connection for melanoma of the left chest and squamous cell carcinoma of the right temple and above the left eyebrow, finding a link to herbicide exposure in service. The issue regarding a lymph node disability, diagnosed as esophageal cancer, was remanded.

The Board denied the veteran's claims for increased ratings and service connection, finding no evidence of characteristic prostrating attacks for his daily headache or sufficient severity for a higher rating, and no relationship between his depression, peripheral neuropathy, or skin cancer and his military service.

The Board denied service connection for chronic lymphatic leukemia, skin cancer, right and left lower extremity peripheral neuropathy, hypertension with residuals, and coronary artery disease as there was no evidence of in-service incurrence or continuous symptoms since service.

The Board denied service connection for skin cancer and an initial compensable rating for bilateral hearing loss due to the lack of evidence supporting a current diagnosis of skin cancer and audiometric results not meeting the criteria for a compensable rating.

The Board remands the claim for service connection for basal cell carcinoma as new and relevant evidence has been submitted, warranting readjudication.

The Board denied service connection for a right knee condition, remanded claims for right and left foot conditions, and remanded the claim for skin cancer due to lack of sufficient evidence.

The Board remands the claim for service connection of residuals of skin cancer to obtain an addendum opinion regarding whether the Veteran's basal cell skin cancer is related to active-duty service, including in-service exposure to sunlight.

The Veteran's claim for service connection for hypertension was granted under the PACT Act, while his claims for skin cancer and gout were withdrawn or remanded.